Status:

COMPLETED

Neurofeedback Intervention for Preclinical Alzheimer's Disease

Lead Sponsor:

XuanwuH 2

Collaborating Sponsors:

Beijing Institute of Technology

Conditions:

Alzheimer Disease

Subjective Cognitive Decline

Eligibility:

All Genders

50-79 years

Phase:

NA

Brief Summary

Alzheimer's disease (AD) is the most common form of neurodegenerative disorders leading to dementia. Currently, there has been no effective pharmacologic therapy for this disease. Electroencephalogram...

Detailed Description

Currently, there has been no effective therapy for Alzheimer's disease (AD). Electroencephalogram-based neurofeedback is now considered as a potentially intervention and may positively affect cognitiv...

Eligibility Criteria

Inclusion

  • 50-79 years old, right-handed and Mandarin-speaking subjects;
  • self-experienced persistent decline in cognitive capacity in comparison with a previously normal status and unrelated to an acute event;
  • normal age-adjusted, gender-adjusted and education-adjusted performance on standardised cognitive tests;
  • concerns (worries) associated with memory complaint;
  • failure to meet the criteria for MCI or dementia

Exclusion

  • a history of stroke;
  • major depression (Hamilton Depression Rating Scale score \> 24 points);
  • other central nervous system diseases that may cause cognitive impairment, such as Parkinson's disease, tumors, encephalitis and epilepsy;
  • cognitive impairment caused by traumatic brain injury;
  • systemic diseases, such as thyroid dysfunction, syphilis and HIV;
  • a history of psychosis or congenital mental growth retardation.

Key Trial Info

Start Date :

April 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2019

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04300933

Start Date

April 1 2019

End Date

December 31 2019

Last Update

March 9 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Neurolgy, Xuanwu Hospital of Capital Medical University

Beijing, Beijing Municipality, China, 100053